tiprankstipranks
Myriad Genetics (MYGN)
NASDAQ:MYGN
US Market
MYGN
Myriad Genetics
RESEARCH TOOLSreports

Myriad Genetics (MYGN) Income Statement

429 Followers

Myriad Genetics Income Statement

Last quarter (Q4 2025), Myriad Genetics's total revenue was $209.80M, a decrease of -0.38% from the same quarter last year. In Q4, Myriad Genetics's net income was $-7.90M. See Myriad Genetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 824.50M$ 837.60M$ 753.20M$ 678.40M$ 690.60M
Gross Profit
$ 576.60M$ 585.40M$ 517.00M$ 476.40M$ 493.00M
Operating Expenses
$ 715.90M$ 708.90M$ 774.40M$ 617.00M$ 683.50M
Depreciation and Amortization
$ -14.40M$ 61.20M$ 61.90M$ 52.70M$ 62.80M
EBITDA
$ -397.40M$ -59.50M$ -197.40M$ -84.70M$ 12.30M
Operating Income
$ -139.30M$ -123.50M$ -257.40M$ -140.60M$ -190.50M
Other Income/Expenses
$ -255.80M$ 0.00$ -4.80M$ 0.00$ 133.40M
Pretax Income
$ -395.10M$ -123.50M$ -262.20M$ -140.60M$ -57.10M
Net Income
$ -365.90M$ -127.30M$ -263.30M$ -112.00M$ -27.20M
Per Share Metrics
Basic EPS
$ -3.96$ -1.41$ -3.18$ -1.39$ -0.35
Diluted EPS
$ -3.96$ -1.41$ -3.18$ -1.39$ -0.35
Weighted Average Shares Outstanding
 93.30M 90.60M 82.80M 80.58M 77.71M
Weighted Average Shares Outstanding (Diluted)
 93.30M 90.60M 82.80M 80.60M 78.00M
Currency in USD

Myriad Genetics Earnings and Revenue History